Muscle Relaxant Drugs Market Size, Share, And Growth Report 2032

Muscle Relaxant Drugs Market: Size

The global Muscle Relaxant Drugs Market size was worth around USD 4.39 billion in 2023 and is predicted to grow to around USD 7.74 billion by 2032 with a compound annual growth rate (CAGR) of roughly 6.5% between 2024 and 2032.

The study provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD billion). The report covers a forecast and an analysis of the Muscle Relaxant Drugs Market on a global and regional level.

Request Free Sample

Muscle Relaxant Drugs Market: Overview

The skeletal muscle relaxant drugs are a heterogeneous group of medicines that acts both peripherally and centrally to relieve one from muscle spasms. Majorly the muscle relaxants are used to treat two conditions—muscular spasms or pain from injuries, such as low back pain or peripheral musculoskeletal diseases and spasticity from upper motor neuron syndromes that occur in multiple sclerosis.

The muscle relaxant drugs market is currently being driven by the ever-increasing popularization of anti-aging medicines among the global population and the rising trend of spas and salons. Increasing geriatric population, approval of fresh label signs, rising skin-related issues, and escalating surgeries performed worldwide are other main factors boosting the development of the market for muscle relaxant drugs market. However, some serious side-effects linked to use of muscle relaxing drugs, such as respiratory arrest and habituations, are likely to limit the worldwide expansion of the muscle relaxant drugs market. In the U.S., low back pain is among the most common causes of visits to a physician or doctor. On the other hand, doctors and physicians suggest skeletal muscle relaxants as a secondary treatment option for lower back pain. Although muscle relaxants medications are not the primary treatment option, about 40% patients in the U.S. are prescribed muscle relaxants for non-specific low back pain.

Request Free Sample

Muscle Relaxant Drugs Market: Segmentation

The study provides a decisive view of the global muscle relaxant drugs market is segmented based on drug type, distribution channel, and region.

By drug type, the market is divided into facial muscle relaxant drugs, neuromuscular blocking agents, and skeletal muscle relaxant drugs.

Based on the distribution channel, the market for muscle relaxant drugs includes hospitals pharmacy, online pharmacy, and retail pharmacy.

Muscle Relaxant Drugs Market: Report Scope

Muscle Relaxant Drugs Market: Regional Analysis

The regional segment includes North America, Latin America, Asia Pacific, Europe, and the Middle East and Africa.

North America accounted for a major share of the muscle relaxant drugs market globally in 2023 and is likely to remain dominant over the forecast time period. This regional dominance can be attributed to the growing number of new drug applications in North America and the regional presence of a large number of renowned companies. Europe held the second spot in the market for muscle relaxant drugs. The Asia Pacific is expected to register a high CAGR in the muscle relaxant drugs market globally over the estimated time period, owing to the growing base of the aging population in countries like Japan.

Muscle Relaxant Drugs Market: Competitive Players

Some main players in the muscle relaxant drugs market are

• Abbott Laboratories
• Medtronic
• Mallinckrodt
• Vertical Pharmaceuticals
• Par Sterile Products
• Johnson & Johnson
• SteriMax
• Endo Pharmaceuticals

The Global Muscle Relaxant Drugs Market is segmented as follows:

By Drug Type Analysis

• Facial Muscle Relaxant Drugs
• Skeletal Muscle Relaxant Drugs
• Neuromuscular Blocking Agents

By Distribution Channel Analysis

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

By Regional Analysis

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa